Phase 2 Study May Be Added to Ongoing Trial of Combo Ovarian Cancer Immunotherapy
News
Immunovaccine and Incyte Corporation are expanding their collaboration on a clinical trial, and plan to add a Phase 2 to their ongoing Phase 1b study in advanced ovarian cancer. The ... Read more